{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:33:21Z","timestamp":1777534401036,"version":"3.51.4"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011074","name":"Liver Center, University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA250227"],"award-info":[{"award-number":["R01CA250227"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA204586"],"award-info":[{"award-number":["R01CA204586"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ajpath.2021.01.010","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T15:42:55Z","timestamp":1612366975000},"page":"930-946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Loss of Apc Cooperates with Activated Oncogenes to Induce Liver Tumor Formation in Mice"],"prefix":"10.1016","volume":"191","author":[{"given":"Yi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binyong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinhua","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haichuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Evert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego F.","family":"Calvisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6640-0857","authenticated-orcid":false,"given":"Liling","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9588-0164","authenticated-orcid":false,"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2021.01.010_bib1","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajpath.2021.01.010_bib2","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/jhep.2003.50375","article-title":"Epidemiology of primary hepatic malignancies in U.S. children","volume":"38","author":"Darbari","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2021.01.010_bib3","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3390\/cancers11070926","article-title":"Wnt\/beta-catenin signaling in liver cancers","volume":"11","author":"Wang","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ajpath.2021.01.010_bib4","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jhep.2017.03.011","article-title":"Global trends and predictions in hepatocellular carcinoma mortality","volume":"67","author":"Bertuccio","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2021.01.010_bib5","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/modpathol.2013.80","article-title":"Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium","volume":"27","author":"L\u00f3pez-Terrada","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2021.01.010_bib6","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/beta-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2021.01.010_bib7","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1101\/gad.1424006","article-title":"Wnt signaling: is the party in the nucleus?","volume":"20","author":"Willert","year":"2006","journal-title":"Genes Dev"},{"key":"10.1016\/j.ajpath.2021.01.010_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41575-018-0075-9","article-title":"Wnt-beta-catenin signalling in liver development, health and disease","volume":"16","author":"Perugorria","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2021.01.010_bib9","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3390\/cancers11101406","article-title":"The emerging roles of cancer stem cells and Wnt\/beta-catenin signaling in hepatoblastoma","volume":"11","author":"Mavila","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ajpath.2021.01.010_bib10","doi-asserted-by":"crossref","first-page":"D777","DOI":"10.1093\/nar\/gkw1121","article-title":"COSMIC: somatic cancer genetics at high-resolution","volume":"45","author":"Forbes","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ajpath.2021.01.010_bib11","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1074\/jbc.M111.323337","article-title":"Adenomatous polyposis coli (APC) regulates multiple signaling pathways by enhancing glycogen synthase kinase-3 (GSK-3) activity","volume":"287","author":"Valvezan","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2021.01.010_bib12","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.3892\/or.2013.2681","article-title":"APC germline mutations in families with familial adenomatous polyposis","volume":"30","author":"De Queiroz Rossanese","year":"2013","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ajpath.2021.01.010_bib13","first-page":"1738696","article-title":"From the gut to the liver: another organ to watch in FAP patients","volume":"2016","author":"Paulson","year":"2016","journal-title":"Case Rep Pathol"},{"key":"10.1016\/j.ajpath.2021.01.010_bib14","doi-asserted-by":"crossref","first-page":"e26892","DOI":"10.1002\/pbc.26892","article-title":"Germline APC mutations in hepatoblastoma","volume":"65","author":"Yang","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ajpath.2021.01.010_bib15","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/pbc.20698","article-title":"Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations?","volume":"47","author":"Aretz","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ajpath.2021.01.010_bib16","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/ajmg.1320430621","article-title":"Risk of hepatoblastoma in familial adenomatous polyposis","volume":"43","author":"Hughes","year":"1992","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ajpath.2021.01.010_bib17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/hmg\/10.7.721","article-title":"The ABC of APC","volume":"10","author":"Fearnhead","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2021.01.010_bib18","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1007\/s13277-015-4002-1","article-title":"Gene mutations in gastric cancer: a review of recent next-generation sequencing studies","volume":"36","author":"Lin","year":"2015","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ajpath.2021.01.010_bib19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/humu.1380020602","article-title":"Mutations of the APC (adenomatous polyposis coli) gene","volume":"2","author":"Nagase","year":"1993","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ajpath.2021.01.010_bib20","first-page":"713","article-title":"Multi-layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT\/beta-catenin signaling activation (Review)","volume":"42","author":"Katoh","year":"2018","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.ajpath.2021.01.010_bib21","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ng.2256","article-title":"Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma","volume":"44","author":"Guichard","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2021.01.010_bib22","doi-asserted-by":"crossref","first-page":"e1583547","DOI":"10.1080\/2162402X.2019.1583547","article-title":"APC germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structures","volume":"8","author":"Morcrette","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ajpath.2021.01.010_bib23","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","article-title":"Hippo pathway in organ size control, tissue homeostasis, and cancer","volume":"163","author":"Yu","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2021.01.010_bib24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00018-014-1742-9","article-title":"The mammalian Hippo pathway: regulation and function of YAP1 and TAZ","volume":"72","author":"Kodaka","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ajpath.2021.01.010_bib25","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.tibs.2017.09.003","article-title":"Regulation of the Hippo pathway transcription factor TEAD","volume":"42","author":"Lin","year":"2017","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.ajpath.2021.01.010_bib26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ceb.2019.07.006","article-title":"Role of the transcriptional coactivators YAP\/TAZ in liver cancer","volume":"61","author":"Zhang","year":"2019","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.ajpath.2021.01.010_bib27","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1053\/j.gastro.2016.10.047","article-title":"Hippo signaling in the liver regulates organ size, cell fate, and carcinogenesis","volume":"152","author":"Patel","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2021.01.010_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1478-3231.2011.02646.x","article-title":"Deregulation of Hippo kinase signalling in human hepatic malignancies","volume":"32","author":"Li","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.ajpath.2021.01.010_bib29","doi-asserted-by":"crossref","first-page":"20484","DOI":"10.1038\/srep20484","article-title":"Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1\/FASN pathway in mice","volume":"6","author":"Hu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2021.01.010_bib30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fcell.2020.00055","article-title":"The function of the HGF\/c-Met axis in hepatocellular carcinoma","volume":"8","author":"Wang","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.ajpath.2021.01.010_bib31","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1177\/1758834011422556","article-title":"An overview of the c-MET signaling pathway","volume":"3","author":"Organ","year":"2011","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.ajpath.2021.01.010_bib32","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.3748\/wjg.v24.i33.3695","article-title":"Updates on the hepatocyte growth factor\/c-Met axis in hepatocellular carcinoma and its therapeutic implications","volume":"24","author":"Garcia-Vilas","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ajpath.2021.01.010_bib33","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/hep.29496","article-title":"Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma","volume":"67","author":"Bouattour","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2021.01.010_bib34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/annonc\/mds520","article-title":"Seminars in clinical pharmacology: an introduction to MET inhibitors for the medical oncologist","volume":"24","author":"Fasolo","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ajpath.2021.01.010_bib35","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/jcph.148","article-title":"Population pharmacokinetic analysis from phase I and phase II studies of the humanized monovalent antibody, onartuzumab (MetMAb), in patients with advanced solid tumors","volume":"53","author":"Xin","year":"2013","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ajpath.2021.01.010_bib36","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrc1912","article-title":"Invasive growth: a MET-driven genetic programme for cancer and stem cells","volume":"6","author":"Boccaccio","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2021.01.010_bib37","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.ajpath.2020.03.011","article-title":"The Hippo effector transcriptional coactivator with PDZ-binding motif cooperates with oncogenic beta-catenin to induce hepatoblastoma development in mice and humans","volume":"190","author":"Zhang","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2021.01.010_bib38","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/hep.22169","article-title":"Integration of genomic analysis and in\u00a0vivo transfection to identify sprouty 2 as a candidate tumor suppressor in liver cancer","volume":"47","author":"Lee","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2021.01.010_bib39","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1158\/0008-5472.CAN-08-2514","article-title":"Role of cyclin D1 as a mediator of c-Met- and beta-catenin-induced hepatocarcinogenesis","volume":"69","author":"Patil","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2021.01.010_bib40","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/hep.28601","article-title":"Modeling a human hepatocellular carcinoma subset in mice through coexpression of met and point-mutant beta-catenin","volume":"64","author":"Tao","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2021.01.010_bib41","doi-asserted-by":"crossref","first-page":"14771","DOI":"10.1073\/pnas.0706578104","article-title":"Distinct pathways of genomic progression to benign and malignant tumors of the liver","volume":"104","author":"Tward","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2021.01.010_bib42","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.ajpath.2013.12.002","article-title":"Hydrodynamic transfection for generation of novel mouse models for liver cancer research","volume":"184","author":"Chen","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2021.01.010_bib43","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Comprehensive and integrative genomic characterization of hepatocellular carcinoma","volume":"169","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2021.01.010_bib44","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1172\/JCI31457","article-title":"Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma","volume":"117","author":"Calvisi","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2021.01.010_bib45","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/hep.27732","article-title":"DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma","volume":"61","author":"Villanueva","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2021.01.010_bib46","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1186\/s12864-015-1847-z","article-title":"MEXPRESS: visualizing expression, DNA methylation and clinical TCGA data","volume":"16","author":"Koch","year":"2015","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ajpath.2021.01.010_bib47","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/hep.28888","article-title":"Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups","volume":"65","author":"Sumazin","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2021.01.010_bib48","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/hep.30556","article-title":"Axis inhibition protein 1 (Axin1) deletion-induced hepatocarcinogenesis requires intact beta-catenin but not Notch cascade in mice","volume":"70","author":"Qiao","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2021.01.010_bib49","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.jhep.2014.06.033","article-title":"YAP activation is an early event and a potential therapeutic target in liver cancer development","volume":"61","author":"Perra","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2021.01.010_bib50","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1093\/molbev\/msr065","article-title":"The evolutionary history of YAP and the hippo\/YAP pathway","volume":"28","author":"Hilman","year":"2011","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.ajpath.2021.01.010_bib51","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jcmgh.2020.11.008","article-title":"Distinct and overlapping roles of Hippo effectors YAP and TAZ during human and mouse hepatocarcinogenesis","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2021.01.010_bib52","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1053\/j.gastro.2014.05.004","article-title":"Activation of beta-catenin and Yap1 in human hepatoblastoma and induction of\u00a0hepatocarcinogenesis in mice","volume":"147","author":"Tao","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2021.01.010_bib53","article-title":"Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma","author":"Shang","year":"2020","journal-title":"Gut"},{"issue":"Suppl 2","key":"10.1016\/j.ajpath.2021.01.010_bib54","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00292-011-1529-9","article-title":"[De novo lipogenesis: role in hepatocellular carcinoma]. German","volume":"32","author":"Calvisi","year":"2011","journal-title":"Pathologe"},{"key":"10.1016\/j.ajpath.2021.01.010_bib55","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10555-017-9725-6","article-title":"Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting","volume":"37","author":"Hankey","year":"2018","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.ajpath.2021.01.010_bib56","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1126\/science.1259472","article-title":"Metabolism. Differential regulation of mTORC1 by leucine and glutamine","volume":"347","author":"Jewell","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2021.01.010_bib57","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.cmet.2019.01.002","article-title":"Inhibiting glutamine-dependent mTORC1 activation ameliorates liver cancers driven by beta-catenin mutations","volume":"29","author":"Adebayo Michael","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.ajpath.2021.01.010_bib58","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/1535370217708198","article-title":"Discovery of small molecule inhibitors of the Wnt\/beta-catenin signaling pathway by targeting beta-catenin\/Tcf4 interactions","volume":"242","author":"Yan","year":"2017","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.ajpath.2021.01.010_bib59","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/hep.28975","article-title":"Targeting beta-catenin in hepatocellular cancers induced by coexpression of mutant beta-catenin and K-Ras in mice","volume":"65","author":"Tao","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2021.01.010_bib60","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1242\/jcs.03485","article-title":"Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene","volume":"120","author":"Aoki","year":"2007","journal-title":"J Cell Sci"},{"key":"10.1016\/j.ajpath.2021.01.010_bib61","doi-asserted-by":"crossref","first-page":"17216","DOI":"10.1073\/pnas.0404761101","article-title":"Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas","volume":"101","author":"Colnot","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2021.01.010_bib62","doi-asserted-by":"crossref","first-page":"25390","DOI":"10.18632\/oncotarget.4455","article-title":"Tankyrase inhibitors attenuate WNT\/beta-catenin signaling and inhibit growth of hepatocellular carcinoma cells","volume":"6","author":"Ma","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2021.01.010_bib63","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10654-011-9647-5","article-title":"Enigmatic sex disparities in cancer incidence","volume":"27","author":"Edgren","year":"2012","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ajpath.2021.01.010_bib64","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1158\/1055-9965.EPI-11-0246","article-title":"Sex disparities in cancer mortality and survival","volume":"20","author":"Cook","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ajpath.2021.01.010_bib65","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1158\/0008-5472.CAN-18-0362","article-title":"Sex differences in cancer driver genes and biomarkers","volume":"78","author":"Li","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2021.01.010_bib66","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1038\/s41467-020-17359-2","article-title":"Sex differences in oncogenic mutational processes","volume":"11","author":"Li","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2021.01.010_bib67","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13293-020-00291-x","article-title":"Sex differences in cancer mechanisms","volume":"11","author":"Rubin","year":"2020","journal-title":"Biol Sex Differ"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944021000419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944021000419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:55:25Z","timestamp":1777395325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944021000419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0002944021000419"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2021.01.010","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of Apc Cooperates with Activated Oncogenes to Induce Liver Tumor Formation in Mice","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2021.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Society for Investigative Pathology. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}